
Brian L. Cassidy
Examiner (ID: 19285, Phone: (571)270-7237 , Office: P/3618 )
| Most Active Art Unit | 3618 |
| Art Unit(s) | 3618 |
| Total Applications | 301 |
| Issued Applications | 235 |
| Pending Applications | 1 |
| Abandoned Applications | 64 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18474636
[patent_doc_number] => 20230208924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => INTRAVENOUS ADMINISTRATION OF SUPRAPHYSIOLOGIC PLATELET RICH PLASMA FOR NEUROLOGICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/111439
[patent_app_country] => US
[patent_app_date] => 2023-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8306
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18111439
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/111439 | INTRAVENOUS ADMINISTRATION OF SUPRAPHYSIOLOGIC PLATELET RICH PLASMA FOR NEUROLOGICAL DISORDERS | Feb 16, 2023 | Pending |
Array
(
[id] => 18647909
[patent_doc_number] => 20230293688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => FUSOGENIC RHABDOVIRUS GLYCOPROTEINS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/167444
[patent_app_country] => US
[patent_app_date] => 2023-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18167444
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/167444 | FUSOGENIC RHABDOVIRUS GLYCOPROTEINS AND USES THEREOF | Feb 9, 2023 | Pending |
Array
(
[id] => 18647909
[patent_doc_number] => 20230293688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => FUSOGENIC RHABDOVIRUS GLYCOPROTEINS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/167444
[patent_app_country] => US
[patent_app_date] => 2023-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18167444
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/167444 | FUSOGENIC RHABDOVIRUS GLYCOPROTEINS AND USES THEREOF | Feb 9, 2023 | Pending |
Array
(
[id] => 18806908
[patent_doc_number] => 20230381241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => METHODS OF MANUFACTURE OF IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 18/094148
[patent_app_country] => US
[patent_app_date] => 2023-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18094148
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/094148 | Methods of manufacture of immunocompatible chorionic membrane products | Jan 5, 2023 | Issued |
Array
(
[id] => 18628483
[patent_doc_number] => 20230287348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHOD FOR THE GENERATION OF GENETICALLY MODIFIED CELLS
[patent_app_type] => utility
[patent_app_number] => 18/147891
[patent_app_country] => US
[patent_app_date] => 2022-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18147891
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/147891 | METHOD FOR THE GENERATION OF GENETICALLY MODIFIED CELLS | Dec 28, 2022 | Pending |
Array
(
[id] => 18628483
[patent_doc_number] => 20230287348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHOD FOR THE GENERATION OF GENETICALLY MODIFIED CELLS
[patent_app_type] => utility
[patent_app_number] => 18/147891
[patent_app_country] => US
[patent_app_date] => 2022-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18147891
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/147891 | METHOD FOR THE GENERATION OF GENETICALLY MODIFIED CELLS | Dec 28, 2022 | Pending |
Array
(
[id] => 18334371
[patent_doc_number] => 20230126319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => Products Derived from Amniotic Fluid and Methods of Use
[patent_app_type] => utility
[patent_app_number] => 18/081136
[patent_app_country] => US
[patent_app_date] => 2022-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -85
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18081136
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/081136 | Products Derived from Amniotic Fluid and Methods of Use | Dec 13, 2022 | Pending |
Array
(
[id] => 18536049
[patent_doc_number] => 20230241136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => HISTAMINE-PRODUCING BACTERIAL STRAINS AND THEIR USE IN CANCER
[patent_app_type] => utility
[patent_app_number] => 18/060626
[patent_app_country] => US
[patent_app_date] => 2022-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18060626
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/060626 | HISTAMINE-PRODUCING BACTERIAL STRAINS AND THEIR USE IN CANCER | Nov 30, 2022 | Pending |
Array
(
[id] => 18536049
[patent_doc_number] => 20230241136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => HISTAMINE-PRODUCING BACTERIAL STRAINS AND THEIR USE IN CANCER
[patent_app_type] => utility
[patent_app_number] => 18/060626
[patent_app_country] => US
[patent_app_date] => 2022-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18060626
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/060626 | HISTAMINE-PRODUCING BACTERIAL STRAINS AND THEIR USE IN CANCER | Nov 30, 2022 | Pending |
Array
(
[id] => 18336987
[patent_doc_number] => 20230128936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHODS OF MANUFACTURE OF IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/971980
[patent_app_country] => US
[patent_app_date] => 2022-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17971980
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/971980 | METHODS OF MANUFACTURE OF IMMUNOCOMPATIBLE AMNIOTIC MEMBRANE PRODUCTS | Oct 23, 2022 | Pending |
Array
(
[id] => 18309245
[patent_doc_number] => 20230113145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/969461
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969461
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/969461 | IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS | Oct 18, 2022 | Pending |
Array
(
[id] => 18309245
[patent_doc_number] => 20230113145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/969461
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969461
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/969461 | IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS | Oct 18, 2022 | Pending |
Array
(
[id] => 18309245
[patent_doc_number] => 20230113145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/969461
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969461
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/969461 | IMMUNOCOMPATIBLE CHORIONIC MEMBRANE PRODUCTS | Oct 18, 2022 | Pending |
Array
(
[id] => 18595354
[patent_doc_number] => 20230270142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => COMPOSITION CONTAINING EQUOL AND ORNITHINE
[patent_app_type] => utility
[patent_app_number] => 17/955898
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17955898
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/955898 | COMPOSITION CONTAINING EQUOL AND ORNITHINE | Sep 28, 2022 | Pending |
Array
(
[id] => 18595354
[patent_doc_number] => 20230270142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => COMPOSITION CONTAINING EQUOL AND ORNITHINE
[patent_app_type] => utility
[patent_app_number] => 17/955898
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17955898
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/955898 | COMPOSITION CONTAINING EQUOL AND ORNITHINE | Sep 28, 2022 | Pending |
Array
(
[id] => 18211093
[patent_doc_number] => 20230057356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => ENHANCEMENT OF UMBILICAL CORD MESENCHYMAL STEM CELL THERAPEUTIC ACTIVITY BY STIMULATORS OF T REGULATORY CELLS AND/OR CELLS EXPRESSING CD73
[patent_app_type] => utility
[patent_app_number] => 17/820789
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820789 | ENHANCEMENT OF UMBILICAL CORD MESENCHYMAL STEM CELL THERAPEUTIC ACTIVITY BY STIMULATORS OF T REGULATORY CELLS AND/OR CELLS EXPRESSING CD73 | Aug 17, 2022 | Abandoned |
Array
(
[id] => 18034516
[patent_doc_number] => 20220378731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => Composition For Treating Tauopathy In The Brain, Brain Stem and Spinal Column
[patent_app_type] => utility
[patent_app_number] => 17/884360
[patent_app_country] => US
[patent_app_date] => 2022-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17884360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/884360 | Composition For Treating Tauopathy In The Brain, Brain Stem and Spinal Column | Aug 8, 2022 | Abandoned |
Array
(
[id] => 18109857
[patent_doc_number] => 20230002737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => Methods and Apparatuses for Patient-Derived Micro-Organospheres
[patent_app_type] => utility
[patent_app_number] => 17/874136
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17874136
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/874136 | Methods and Apparatuses for Patient-Derived Micro-Organospheres | Jul 25, 2022 | Pending |
Array
(
[id] => 18869171
[patent_doc_number] => 11856944
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Organ care solution for ex-vivo machine perfusion of donor lungs
[patent_app_type] => utility
[patent_app_number] => 17/869701
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8828
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17869701
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/869701 | Organ care solution for ex-vivo machine perfusion of donor lungs | Jul 19, 2022 | Issued |
Array
(
[id] => 19432848
[patent_doc_number] => 20240301346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => CELLULAR MICROCOMPARTMENTS COMPRISING CELLS OF WHICH THE GENOMIC INTEGRITY IS MAINTAINED AFTER AMPLIFICATION AND PREPARATION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/270924
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270924
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/270924 | CELLULAR MICROCOMPARTMENTS COMPRISING CELLS OF WHICH THE GENOMIC INTEGRITY IS MAINTAINED AFTER AMPLIFICATION AND PREPARATION METHOD | May 10, 2022 | Pending |